Hepion Pharmaceuticals, Inc. (HEPA): Cash & Equivalents

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$13.92M
As of 2019-12-31
2017-06-30: $12.98M2017-12-31: $5.95M2018-12-31: $2.83M2019-12-31: $13.92M$13.92M
2017-06-30 Cash & Equivalents (USD) 2019-12-31
Period endedCash & EquivalentsChange YoYSource filing
2019-12-31$13.92M+391.6%2020-05-14, Balance as of period end
2018-12-31$2.83M-52.4%2020-05-14, Balance as of period end
2017-12-31$5.95Mn/a2019-03-14, Balance as of period end
2017-06-30$12.98Mn/a2019-03-14, Balance as of period end